Last Updated:
2:29 pm
Friday, June 20, 2025
Anagenics Ltd. is a biotechnology company, which engages in the development and marketing of therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. It operates through the Anagenics Corporate and Consumer and Health segments. The company was founded on October 8, 2004 and is headquartered in Sydney, Australia.
asx-an1
Market Cap
AU$3.47M
Volume
226000
Open
0.01
AU$
High
0.01
AU$
Low
0.01
AU$
Shares On Issue
461M
52 Week Low
0.005
AU$
52 Week High
0.01
AU$
Website
Consensus
N/A
Last Report Date
N/A
Next Report Date
N/A
Next Dividend date
N/A
Short Sell
N/A
Short Sell Change (1mth)
N/A
Free ASX Market Outlook & Top Stock Picks for 2025
Instantly access our exclusive report and see which stocks our analysts are backing for growth this year.
Download Free Report
Related
Our friendly team is here to help.
If you have any questions or feedback about our service, please feel free to contact us.
© Australian Stock Report Pty Ltd. All rights reserved